Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

A new Mayo Clinic study found the prostate-specific antigen test was accurate in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a news ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

This week Bobbi Conner talks with Dr. Eric Wallen about prostate cancer screening. Dr. Wallen is a Professor and Chair of the Urology Department at MUSC. TRANSCRIPT: Conner: I'm B ...

OncoAssure Ltd, an Irish medical diagnostic company, today announced the publication of new data, in the British Journal of Urology International Compass (BJUI Compass), which demonstrates the ...

Please provide your email address to receive an email when new articles are posted on . MyProstateScore 2.0 showed high sensitivity for detecting aggressive prostate cancer without the need for a ...

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. To confirm the diagnosis, biopsies are required. A team of researchers has now ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.

There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because ...